Tirzepatide 30mg
$250.00
Tirzepatide 30mg is a GLP-1 and metabolic research peptide for laboratory research. Review product details, COA/lab testing, research-use guidance, and shipping information from Polaris Peptide.
Description
Tirzepatide 30mg Research Product Overview
Tirzepatide 30mg is available from Polaris Peptide for qualified laboratory research, analytical workflows, and controlled in-vitro study environments. This product page is written for researchers who want clear product information before they buy Tirzepatide 30mg online for research use. The listing keeps the focus on product identity, strength, handling expectations, quality documentation, and the internal resources needed to review the item before placing an order.
Tirzepatide 30mg Product Details
Tirzepatide 30mg is categorized under GLP-1 & GIP Analogues and is listed as SKU PLT30. The selected product strength is 30mg. Buy Tirzepatide 30 mg – Dual GLP-1/GIP-Receptor Agonist Peptide, High Purity Lyophilized 30 mg vial, >99 % purity (HPLC-MS) and vacuum-sealed. Store -20 degrees C dry; 2-8 degrees C reconstituted; complete work within 28 days. For laboratory research only. Not intended for human or veterinary applications. Polaris Peptide presents this information so researchers can compare the product name, size, category, and available laboratory data in one place before adding the item to a research supply order.
Tirzepatide 30mg COA, Lab Testing, and Quality Information
Researchers reviewing Tirzepatide 30mg should check the COA/Lab Testing information, batch notes, purity details, mass data, and any chemical information shown below. Where available, this page includes chemical identifiers, molecular formula, molecular weight, latest lab results, and previous lab-result summaries. These details help make the product page more useful for product comparison, documentation review, and purchase decisions while keeping the page aligned with research-use-only language.
Buy Tirzepatide 30mg from Polaris Peptide
Buy Tirzepatide 30 mg — Dual GLP‑1/GIP‑Receptor Agonist Peptide, High Purity
Lyophilized 30 mg vial, >99 % purity (HPLC‑MS) and vacuum‑sealed. Store −20 °C dry; 2–8 °C reconstituted; complete work within 28 days. For laboratory research only. Not intended for human or veterinary applications. ‘Tirzepatide 30mg research peptide vial’. This item is not intended for human or veterinary use, clinical use, diagnostic use, therapeutic use, or consumer use.
Chemical Info
| CID | 156588324 |
|---|---|
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | 4813 g/mol |
Latest Lab Results
- TrustPointe Analytics – December 16, 2025: Avg. Mass: 34.469mg; Avg. Purity: 99.918%; Batch: POL-T30-17
Previous Lab Results
- TrustPointe Analytics – October 15, 2025: Avg. Mass: 35.526mg; Avg. Purity: 99.850%; Batch: POL-T-30-16
- JANOSHIK – July 29, 2025: Avg. Mass: 32.53mg; Avg. Purity: 99.87%; Batch: POL-T30-14
- TrustPointe Analytics – July 29, 2025: Avg. Mass: 36.788mg; Avg. Purity: 99.726%; Batch: POL-T30-15
- TrustPointe Analytics – April 21, 2025: Avg. Mass: 32.931mg; Avg. Purity: 99.888%; Batch: POL-T30-11
- Janoshik – February 3, 2025: Avg. Mass: 32.19mg; Avg. Purity: 99.7693%; Batch: POL-T30-12
- Chromate – October 4, 2024: Avg. Purity: 99.731%; Avg. Mass: 35.22mg; Batch: POL-T30-9
- Chromate – September 25, 2024: Avg. Purity: 99.62437.46; Batch: POL-T30-7
- Janoshik – September 11, 2024: Avg. Purity: 99.794%; Avg. Mass: 31.63mg; Batch: POL-T30-6
- Janoshik – September 11, 2024: Endotoxin: 0.002 $ 0.001 EU; Batch: POL-T30-6
- Janoshik – September 11, 2024: As: None Detected; Cd: None Detected; Hg: None detected; Batch: POL-T30-6
- Janoshik – July 24, 2024: Endotoxin: 0.002 $ 0.001 EU; Batch: POL-T30-5
- Janoshik – July 12, 2024: Avg. Purity: 99.76%; Avg. Mass: 32.75mg; Batch: POL-T30-5
- Janoshik – July 12, 2024: Cadmium: Not Detected; Mercury: Not Detected; Arsenic: Not Detected; Batch: POL-T30-5
- Janoshik – July 12, 2024: Endotoxin: 0.002 +/- 0.001 EU; Batch: POL-T30-5
- Janoshik – July 12, 2024: As: not detected; Cd: not detected; Hg: not detected; Batch: POL-T30-5
- Chromate – July 6, 2024: Avg. Purity: 99.514%; Avg. Mass: 33.74mg; Batch: POL-T30-5
- Janoshik – May 29, 2024: Avg. Purity: 99.759%; Avg. Mass: 32.67mg; Batch: POL-T30-2
- Janoshik – February 29, 2024: Avg. Purity: 99.832%; Avg. Mass: 34.36mg; Batch: POL-T30-1
Helpful Polaris Peptide resources: View our research peptide shop, COA/Lab Testing, Research Use Disclaimer, Shipping & Payment, and FAQ.
Additional information
| Weight/Mass | 30mg |
|---|
Reviews
There are no reviews yet.